(Q35621312)

9 August 2017

Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma (English)

1 reference

9 August 2017

hepatocellular carcinoma

1 reference

Chaur-Shine Wang

1

1 reference

9 August 2017

Chih-Lin Lin

2

1 reference

9 August 2017

Hsi-Chang Lee

3

1 reference

9 August 2017

Kuan-Yang Chen

4

1 reference

9 August 2017

Ming-Feng Chiang

5

1 reference

9 August 2017

Hung-Sheng Chen

6

1 reference

9 August 2017

Tsung-Jung Lin

7

1 reference

9 August 2017

Li-Ying Liao

8

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

World Journal of Gastroenterology

9 August 2017

1 reference

9 August 2017

11

1 reference

9 August 2017

39

1 reference

9 August 2017

6115-6119

1 reference

Primary liver cancer: worldwide incidence and trends

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Randomized controlled trial of screening for hepatocellular carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Epidemiology of primary liver cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Current treatment modalities for hepatocellular carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4436626

Transection of the oesophagus for bleeding oesophageal varices

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.3748%2FWJG.V11.I39.6115

Hepatocellular carcinoma: importance of histologic classification as a prognostic factor

21 January 2018

1 reference

12 December 2020

Usefulness of ED036 kit for measuring serum PIVKA-II levels in small hepatocellular carcinoma

1 reference

12 December 2020

Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group

1 reference

12 December 2020

Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients

1 reference

12 December 2020

Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma

1 reference

12 December 2020

Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity

1 reference

12 December 2020

The diagnostic value of the assay of des-gamma-carboxy prothrombin in the detection of small hepatocellular carcinoma

1 reference

12 December 2020

Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study

1 reference

12 December 2020

The natural history of hepatocellular carcinoma. A study of 100 untreated cases

1 reference

12 December 2020

The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma

1 reference

12 December 2020

Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment

1 reference

12 December 2020

Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma

1 reference

12 December 2020

A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma

1 reference

12 December 2020

Clinical evaluation of plasma abnormal prothrombin (des-gamma-carboxy prothrombin) in hepatobiliary malignancies and other diseases

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I39.6115

1 reference

9 August 2017

1 reference

9 August 2017

1 reference